Volume 137, Issue 3, Pages e3 (September 2009)

Slides:



Advertisements
Similar presentations
Pathogenic and Protective Roles of MyD88 in Leukocytes and Epithelial Cells in Mouse Models of Inflammatory Bowel Disease  Mark J. Asquith, Olivier Boulard,
Advertisements

Volume 141, Issue 5, Pages e10 (November 2011)
Volume 132, Issue 2, Pages (February 2007)
CD44 Deficiency Attenuates Chronic Murine Ileitis
Volume 140, Issue 2, Pages e2 (February 2011)
Xiaolun Sun, Deborah Threadgill, Christian Jobin  Gastroenterology 
Volume 133, Issue 4, Pages (October 2007)
Volume 143, Issue 5, Pages (November 2012)
Volume 139, Issue 1, Pages e7 (July 2010)
Volume 135, Issue 2, Pages e1 (August 2008)
Volume 133, Issue 6, Pages (December 2007)
Differential Effects of Gut-Homing Molecules CC Chemokine Receptor 9 and Integrin-β7 during Acute Graft-versus-Host Disease of the Liver  Alina Schreder,
Volume 137, Issue 2, Pages e2 (August 2009)
Volume 141, Issue 1, Pages e2 (July 2011)
Volume 133, Issue 6, Pages e14 (December 2007)
Volume 137, Issue 2, Pages e2 (August 2009)
Volume 31, Issue 5, Pages (November 2009)
Aryl Hydrocarbon Receptor Regulates Pancreatic IL-22 Production and Protects Mice From Acute Pancreatitis  Jing Xue, David T.C. Nguyen, Aida Habtezion 
Volume 142, Issue 5, Pages e4 (May 2012)
Volume 133, Issue 1, Pages (July 2007)
Volume 141, Issue 2, Pages e4 (August 2011)
Volume 134, Issue 4, Pages e2 (April 2008)
Volume 145, Issue 2, Pages e10 (August 2013)
Volume 137, Issue 6, Pages e2 (December 2009)
Volume 21, Issue 13, Pages (December 2017)
Volume 134, Issue 2, Pages (February 2008)
Pathogenic and Protective Roles of MyD88 in Leukocytes and Epithelial Cells in Mouse Models of Inflammatory Bowel Disease  Mark J. Asquith, Olivier Boulard,
Volume 141, Issue 5, Pages (November 2011)
Volume 146, Issue 1, Pages e13 (January 2014)
Volume 64, Issue 1, Pages (January 2016)
Volume 145, Issue 2, Pages e10 (August 2013)
Volume 140, Issue 2, Pages (February 2011)
Volume 143, Issue 3, Pages (September 2012)
Volume 140, Issue 1, Pages e4 (January 2011)
Volume 144, Issue 5, Pages e6 (May 2013)
Volume 142, Issue 2, Pages e2 (February 2012)
Volume 132, Issue 3, Pages (March 2007)
Toll-Like Receptor 5 Engagement Modulates Tumor Development and Growth in a Mouse Xenograft Model of Human Colon Cancer  Sang Hoon Rhee, Eunok Im, Charalabos.
Volume 145, Issue 3, Pages e3 (September 2013)
Volume 137, Issue 4, Pages (October 2009)
Volume 9, Issue 4, Pages (October 1998)
Depletion of Host CCR7+ Dendritic Cells Prevented Donor T Cell Tissue Tropism in Anti- CD3–Conditioned Recipients  Wei He, Jeremy J. Racine, Heather F.
Volume 141, Issue 5, Pages (November 2011)
Volume 130, Issue 2, Pages (February 2006)
Volume 134, Issue 4, Pages e2 (April 2008)
Volume 127, Issue 1, Pages (July 2004)
Volume 139, Issue 6, Pages (December 2010)
Volume 143, Issue 3, Pages e2 (September 2012)
Volume 140, Issue 2, Pages e4 (February 2011)
Volume 133, Issue 4, Pages e3 (October 2007)
Volume 130, Issue 4, Pages (April 2006)
Volume 142, Issue 2, Pages (February 2012)
Volume 132, Issue 1, Pages (January 2007)
Suppression of Apoptosis, Crypt Hyperplasia, and Altered Differentiation in the Colonic Epithelia of Bak-Null Mice  Carrie A. Duckworth, D. Mark Pritchard 
Qinglan Zhao, Yi Wei, Stephen J. Pandol, Lingyin Li, Aida Habtezion 
Volume 146, Issue 7, Pages e4 (June 2014)
Volume 135, Issue 2, Pages e2 (August 2008)
The CD8α Gene Locus Is Regulated by the Ikaros Family of Proteins
Volume 125, Issue 5, Pages (November 2003)
Volume 137, Issue 4, Pages (October 2009)
Ling Zheng, Terrence E. Riehl, William F. Stenson  Gastroenterology 
Volume 12, Issue 5, Pages (May 2000)
Volume 141, Issue 3, Pages (September 2011)
Volume 138, Issue 4, Pages (April 2010)
Volume 141, Issue 5, Pages (November 2011)
Volume 131, Issue 2, Pages (August 2006)
Volume 131, Issue 2, Pages (August 2006)
Volume 31, Issue 5, Pages (November 2009)
Volume 137, Issue 6, Pages e2 (December 2009)
Molecular Therapy - Nucleic Acids
Presentation transcript:

Volume 137, Issue 3, Pages 1006-1018.e3 (September 2009) Expression of the Chemokine Binding Protein M3 Promotes Marked Changes in the Accumulation of Specific Leukocytes Subsets Within the Intestine  Limin Shang, Nanthakumar Thirunarayanan, Abel Viejo–Borbolla, Andrea P. Martin, Milena Bogunovic, Federica Marchesi, Jay C. Unkeless, Yin Ho, Glaucia C. Furtado, Antonio Alcami, Miriam Merad, Lloyd Mayer, Sergio A. Lira  Gastroenterology  Volume 137, Issue 3, Pages 1006-1018.e3 (September 2009) DOI: 10.1053/j.gastro.2009.05.055 Copyright © 2009 AGA Institute Terms and Conditions

Figure 1 Expression pattern of chemokines in intestinal segments. (A) Sampling of intestinal segments for expression analysis is schematically depicted. Total RNA was isolated from 5–7 pieces of duodenum, jejunum, ileum, cecum, proximal colon, and distal colon for each mouse (n = 3). (B) Differential expression of chemokines in intestinal segments. The complementary DNA samples from 5–7 pieces of each intestinal segment were pooled for analysis of messenger RNA. The messenger RNA expression values were normalized to ubiquitin in each sample, and the data shown are the mean of samples isolated from 3 BDF1 mice. Gastroenterology 2009 137, 1006-1018.e3DOI: (10.1053/j.gastro.2009.05.055) Copyright © 2009 AGA Institute Terms and Conditions

Figure 2 Expression of M3 in the intestine of V-M3 mice. (A) Diagram of the V-M3 transgene. p(A), SV40 poly A sequences. (B) M3 messenger RNA expression in different tissues of V-M3 mice. The values were normalized to ubiquitin in each sample. H, Heart; Lu, Lung; K, Kidney; Br, Brain; LI, Large intestine; SI, Small intestine. (C) Western blot analysis of M3 expression in different segments of intestine of V-M3 mice. (D and E) Representative immunostaining for M3 in small intestine of (D) WT and (E) V-M3 mice. Gastroenterology 2009 137, 1006-1018.e3DOI: (10.1053/j.gastro.2009.05.055) Copyright © 2009 AGA Institute Terms and Conditions

Figure 3 PP of V-M3 mice are smaller and have fewer cells than WT PP. (A and B) V-M3 mice had much smaller PP (B, arrows) than WT littermates (A). (C) The percentage of T and B cells in PP of WT and V-M3 mice. (D) Absolute numbers of B and T cells in PP of WT and V-M3 mice. For C and D: WT, n = 3; V-M3, n = 4; **P < .01. Gastroenterology 2009 137, 1006-1018.e3DOI: (10.1053/j.gastro.2009.05.055) Copyright © 2009 AGA Institute Terms and Conditions

Figure 4 The effects of M3 expression on lymphocyte subsets in the intestinal epithelium of V-M3 mice. (A) Representative FACS analysis of intraepithelial T-cell subsets in V-M3 mice. The upper panel was gated on CD3+ T cells, the middle panel was gated on CD8+ T cells, and the bottom panel was gated on CD8αα+ T cells. (B) Quantitative analysis of intraepithelial T-cell subsets in V-M3 mice. The upper panel represents the percentage of CD3+ cells for each T-cell subset, and the bottom panel shows the absolute cell number of each subset (n = 4 for each group, *P < .05, **P < .01). Gastroenterology 2009 137, 1006-1018.e3DOI: (10.1053/j.gastro.2009.05.055) Copyright © 2009 AGA Institute Terms and Conditions

Figure 5 Reduction of CD8+ T cells in the small intestine but not large intestine LP of V-M3 mice. (A) FACS analysis of B and T cells in the small intestine LP of WT and V-M3 mice (n = 4 for each group). (B) FACS analysis of CD4 and CD8 T cells in the small intestine LP of WT and V-M3 mice. The analysis was gated on CD3+ cells (n = 4 for each group, *P < .05). (C) FACS analysis of B and T cells in the large intestine of WT and V-M3 mice (n = 4 for each group). (D) FACS analysis of CD4 and CD8 T cells in the large intestine of WT and V-M3 mice. The analysis was performed on CD3+ cells. Gastroenterology 2009 137, 1006-1018.e3DOI: (10.1053/j.gastro.2009.05.055) Copyright © 2009 AGA Institute Terms and Conditions

Figure 6 Effect of M3 expression on myeloid cell subsets in the LP of WT and V-M3 mice. (A and B) FACS analysis of LPLs in the (A) small intestine and (B) large intestine of WT and V-M3 mice. The lower FACS panel was gated on the CD11b+/CD11clow subset of the upper panel. The R1, R2, and R3 populations in the right panel correspond to the gates in the lower FACS panel (n = 4 for each group, *P < .05, **P < .01, ***P < .001). (C) Cytospin morphology of cells from R1, R2, and R3 gates of CD11b+/CD11clow cells (as shown in A) from the LP of WT mice. (D) Analysis of CD11b+/CD11clow cells from LP of WT mice for eosinophil markers SIGLEC-F and CCR3. The analysis was performed on the CD11b+/CD11clow cells from LP of WT mice. Gastroenterology 2009 137, 1006-1018.e3DOI: (10.1053/j.gastro.2009.05.055) Copyright © 2009 AGA Institute Terms and Conditions

Figure 7 Chemokine receptor profiles of CD8+ IEL T cells and of CD11b+/CD11clow LPL myeloid cells that were affected by M3 expression. (A and B) Quantitative PCR analysis of chemokine receptor profiles of the (A) CD8αβ/TCRαβ+ subset, CD4+/TCRαβ+ subset, and (B) CD8αα/TCRαβ+ subset of IELs in WT mice. (C and D) Chemokine receptor profiles of the (C) eosinophils and (D) CD11b+/CD11clow/MHCII+/Gr-1low macrophages from the LP of WT mice. Gastroenterology 2009 137, 1006-1018.e3DOI: (10.1053/j.gastro.2009.05.055) Copyright © 2009 AGA Institute Terms and Conditions

Figure 8 Effects of M3 expression on DSS-induced myeloid cell accumulation in the colon. (A and B) DSS treatment of C57BL/6 WT mice altered expression of many (A) CC, (B) CXC, and CX3C chemokines in the colon. Chemokines shown here were those significantly altered by DSS treatment (P < .05, n = 5 for WT and n = 3 for WT + DSS). (C) 6V-M3 transgenic mice (dotted line) lost less body weight than WT littermates (solid line) in response to DSS treatment (*P < .05). (D and E) M3 expression reduced DSS-induced (D) dendritic cell, (E) eosinophil, and macrophage accumulation in the colon of 6V-M3 mice (n = 4 per group, *P < .05, **P < .01, ***P < .001). Gastroenterology 2009 137, 1006-1018.e3DOI: (10.1053/j.gastro.2009.05.055) Copyright © 2009 AGA Institute Terms and Conditions

Supplementary Figure 1 Chemokine expression profiles of intestinal segments. Many CC (A), CXC, CX3C, and XC (B) chemokines are expressed in different intestinal segments of BDF1 mice. The expression values were normalized to ubiquitin in each sample and the data shown are the mean of three independent samples (n = 3). Gastroenterology 2009 137, 1006-1018.e3DOI: (10.1053/j.gastro.2009.05.055) Copyright © 2009 AGA Institute Terms and Conditions

Supplementary Figure 2 Interaction of M3 with chemokines expressed in the intestine. Individual sensorgrams showing the interaction of M3 with the murine chemokines CCL5, CCL6, CCL11, CCL22, CCL24, CCL25, and CCL28. No interaction was observed between M3 and murine CXCL12α or TNFα. The chemokines and TNFα were injected at a concentration of 100 nM. Gastroenterology 2009 137, 1006-1018.e3DOI: (10.1053/j.gastro.2009.05.055) Copyright © 2009 AGA Institute Terms and Conditions

Supplementary Figure 3 M3 expression in the gut of V-M3 mice did not affect the lymphocyte homeostasis in spleen or LNs. (A–C) FACS analysis of the relative and absolute number of B and T cells in the spleen (A), inguinal LN (B), and MLN (C) of WT and V-M3 mice (n = 3 for each group). Gastroenterology 2009 137, 1006-1018.e3DOI: (10.1053/j.gastro.2009.05.055) Copyright © 2009 AGA Institute Terms and Conditions